Biotech boom predicted in 2024 by leading Jefferies analyst, following Bristol Meyers-Karuna deal. UNH stock crashes amidst buying opportunities. PAYC stock undervalued after 50% crash to 52-week low. Medifast stock offers great investment potential, yet remains unattractive. Insightful stock analysis reveals hidden gems.